Posted on March 31, 2016 by henrykotula • Posted in Uncategorized • Tagged Antibiotic Resistance, CDC, Clinical Research, Clinical Research Funding, Compromised Immuned Systems, Deadly Infections, Health Policy, Health System, Hospital, Hospital Infection Rates, Infections, New Drug Development, NIH, Patient Safety, Pharmaceuticals, Public Health, Quality of Care, Superbugs • Leave a comment